Totally implanted venous access-associated adverse events in oncology: Results from a prospective 1-year surveillance programme.
Vermeulin T, Lucas M, Marini H, Di Fiore F, Loeb A, Lottin M, Daubert H, Gray C, Guisier F, Sefrioui D, Michel P, de Mil R, Czernichow P, Merle V.
Vermeulin T, et al. Among authors: daubert h.
Bull Cancer. 2018 Nov;105(11):1003-1011. doi: 10.1016/j.bulcan.2018.09.005. Epub 2018 Oct 12.
Bull Cancer. 2018.
PMID: 30322697